Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade

Critical Care Medicine

Volumn 39, Issue 4, 2011, Pages 793-802

  Patel, Nishith N ^a   Toth, Tibor ^b   Jones, Ceri ^a   Lin, Hua ^a   Ray, Paramita ^c   George, Sarah J ^a   Welsh, Gavin ^a   Satchell, Simon C ^a   Sleeman, Philippa ^a   Angelini, Gianni D ^a   Murphy, Gavin J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c WESTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

acute kidney injury; cardiopulmonary bypass; endothelin 1

Indexed keywords

ADENOSINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; NITRIC OXIDE; SITAXSENTAN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CELL STRESS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HYPOXIA; KIDNEY TUBULE; NEPHRITIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79953205881     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206d563     Document Type: Article

References (34)

1. Kellum JA: Acute kidney injury. Crit Care Med 2008; 36:S141-S145. (Pubitemid 351483043)
2. Karkouti K, Wijeysundera DN, Yau TM, et al: Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation 2009; 119:495-502.
3. Mangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203. (Pubitemid 28078200)
4. Dasta JF, Kane-Gill SL, Durtschi AJ, et al: Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 23:1970-1974. (Pubitemid 351768157)
5. Lieberthal W, Nigam SK: Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278:F1-F12. (Pubitemid 30106121)
6. Heyman SN, Lieberthal W, Rogiers P, et al: Animal models of acute tubular necrosis. Curr Opin Crit Care 2002; 8:526-534. (Pubitemid 35388207)
7. Nigwekar SU, Kandula P, Hix JK, et al: Offpump coronary artery bypass surgery and acute kidney injury: A meta-analysis of randomized and observational studies. Am J Kidney Dis 2009; 54:413-423.
8. Zacharias M, Conlon NP, Herbison GP, et al: Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2008; 4:CD003590.
9. Nielsen TW, Maaske CA, Booth NH: Some Comparative Aspects of Porcine Renal Function. Paris, France, Battelle Memorial Institute, 1996.
10. Schmidt-Nielsen B, O'Dell R: Structure and concentrating mechanisms in the mammalian kidney. Am J Physiol 1961; 200: 1119-1124.
11. Murphy GJ, Lin H, Coward RJ, et al: An initial evaluation of post-cardiopulmonary bypass acute kidney injury in swine. Eur J Cardiothorac Surg 2009; 36:849-855.
12. Ascione R, Lloyd CT, Underwood MJ, et al: On-pump versus off-pump coronary revascularization: Evaluation of renal function. Ann Thorac Surg 1999; 68:493-498. (Pubitemid 29521099)
13. Neuhofer W, Pittrow D: Role of endothelin and endothelin receptor antagonists in renal disease. Eur J Clin Invest 2006; 3(Suppl 36): 78-88. (Pubitemid 44179788)
14. Gellai M, Jugus M, Fletcher T, et al: Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994; 93:900-906.
15. Chade AR, Best PJ, Rodriguez-Porcel M, et al: Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int 2003; 64:962-969. (Pubitemid 37013832)
16. Shoker AS: Application of the clearance concept to hyponatremic and hypernatremic disorders: A phenomenological analysis. Clin Chem 1994; 40:1220-1227. (Pubitemid 24205935)
17. Parikh CR, Mishra J, Thiessen-Philbrook H, et al: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70:199-203. (Pubitemid 44000139)
18. Nims RW, Cook JC, Krishna MC, et al: Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 1996; 68:93-105. (Pubitemid 26286352)
19. Shukla N, Jones R, Persad R, et al: Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharm 2005; 517:224-231. (Pubitemid 40977899)
20. Lim KH, Halestrap AP, Angelini GD, et al: Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med 2005; 230:413-420. (Pubitemid 40827706)
21. Klausner JM, Paterson IS, Goldman G, et al: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989; 256:F794-F802.
22. Muzaffar S, Shukla N, Angelini G, et al: Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 2004; 110: 1140-1147. (Pubitemid 39319015)
23. Coward RJ, Welsh GI, Yang J, et al: The human glomerular podocyte is a novel target for insulin action. Diabetes 2005; 54: 3095-3102. (Pubitemid 43334361)
24. Murphy GJ, Johnson TW, Chamberlain MH, et al: Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts. Cardiovasc Res 2007; 73:607-617. (Pubitemid 46091777)
25. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210. (Pubitemid 36909930)
26. Hammon JW: Extracorporeal circulation: Perfusion system. In: Cardiac Surgery in the Adult. Cohn LH (Ed). New York, NY, McGraw-Hill, 2008, pp 350-370.
27. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
28. Stafford-Smith M, Patel UD, Phillips-Bute BG, et al: Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis 2008 15:257-277. (Pubitemid 351836086)
29. Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238. (Pubitemid 40469655)
30. Ikonomidis JS, Hilton EJ, Payne K, et al: Selective endothelin-A receptor inhibition after cardiac surgery: A safety and feasibility study. Ann Thorac Surg 2007; 83:2153-2161. (Pubitemid 46782682)
31. Lee HT, Xu H, Nasr SH, et al: A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306. (Pubitemid 38141673)
32. Brezis M, Rosen S, Silva P, et al: Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 1984; 25:65-72. (Pubitemid 14159386)
33. Garwood S: Renal insufficiency after cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8:227.
34. Langenberg C, Bagshaw SM, May CN, et al: The histopathology of septic acute kidney injury: A systematic review. Crit Care 2008; 12:R38